Side-by-side comparison
AOD-9604 vs Semaglutide — Price & Profile Comparison
AOD-9604
Cellular PeptideLipolysis research
Semaglutide
GLP-1 PeptideMetabolic / weight research
The short answer
AOD-9604 vs Semaglutide: which to choose
Semaglutide is the cheaper option — roughly $17 vs $57 for the lowest verified listing. Semaglutide is the more widely stocked of the two (35 vendors vs 26). They target different goals — AOD-9604 is a cellular peptide compound while Semaglutide is a glp-1 peptide one — so they're often complementary rather than direct substitutes.
Research products are not for human use. Looking for clinician-supervised care instead? Compare licensed US telehealth providers, published prices, plan terms, and state availability.
Compare supervised options →Price Comparison — 2026
AOD-9604
Semaglutide
Vendors Carrying Both
16 vendors stock both AOD-9604 and Semaglutide — convenient if you want to bundle an order.
Safety Notes
AOD-9604
FDA: Not FDA-approved (GRAS in AU)
6+ RCTs, 900+ participants; no IGF-1 or glucose effects; excellent tolerability; GRAS status in Australia
Semaglutide
FDA: FDA-approved (Ozempic/Wegovy)
Extensive safety data; GI side effects common but manageable; cardiovascular benefit; thyroid warning animal-only
Explore Further
AOD-9604
Semaglutide